May 13, 2021The OncologistOpen Access

Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines

View Full Paper

Ask AI

Bookmark

Medical oncologists selected for clinical practice guidelines panels receive significantly higher personal payments from industry than matched peer physicians.
A nested case-control study shows joining physicians received $11,259 versus $3,427 for controls, evaluated through difference-in-differences analysis of payments.
Selecting panel members with fewer personal payments from industry may reduce commercial influence and improve the objectivity of clinical practice guidelines.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Nested case-control study reveals higher industry payments in oncology guideline authors than matched peers, highlighting potential conflicts of interest.

Cite This Study

Mitchell et al. (2021) studied this question.

synapsesocial.com/papers/6a1e7a949eec3e6c3a55ebca https://doi.org/10.1002/onco.13823

View Full Paper

Ask AI

Bookmark

Implication

Nested case-control study reveals higher industry payments in oncology guideline authors than matched peers, highlighting potential conflicts of interest.

Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines

Key Points

Discussion

Implication

Cite This Study

Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider